TCL Archive Tom King To Leave NCI For Kennedy Ethics Institute; Cal Baldwin To Take NIH Job June 27, 1980
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive DCPC Board approves New CCOP RFA Following Addition Of Public Health, Education Components May 16, 1986
